Deprince Race & Zollo Inc Abbott Laboratories Transaction History

Deprince Race & Zollo Inc

$5.18 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $260,107 - $318,393	-2,884 Reduced 1.08%	264,507 $29.1 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.24 Million - $1.49 Million	12,960 Added 5.09%	267,391 $25.9 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $442,021 - $492,503	-4,386 Reduced 1.69%	254,431 $27.7 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $11.7 Million - $13.8 Million	-120,614 Reduced 31.79%	258,817 $26.2 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.24 Million - $1.45 Million	13,037 Added 3.56%	379,431 $41.7 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $201,454 - $233,246	-2,082 Reduced 0.57%	366,394 $35.5 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $1.67 Million - $2.02 Million	16,381 Added 4.65%	368,476 $40 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $7.34 Million - $8.95 Million	64,369 Added 22.37%	352,095 $41.7 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $863,933 - $1.06 Million	7,478 Added 2.67%	287,726 $40.5 Million
Q3 2021 Nov 17, 2021	SELL	$116.66 - $129.06 $634,513 - $701,957	-5,439 Reduced 1.9%	280,248 $33.1 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $30.2 Million - $35.6 Million	285,687 New	285,687 $33.1 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $17.4 Million - $19.7 Million	-265,476 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$60.81 - $73.36 $4.2 Million - $5.07 Million	-69,100 Reduced 20.65%	265,476 $19.5 Million
Q2 2018 Jul 17, 2018	SELL	$57.57 - $63.54 $1.74 Million - $1.92 Million	-30,156 Reduced 8.27%	334,576 $20.4 Million
Q1 2018 Apr 18, 2018	SELL	$56.27 - $63.62 $9.5 Million - $10.7 Million	-168,858 Reduced 31.65%	364,732 $21.9 Million
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $2.4 Million - $2.57 Million	-44,663 Reduced 7.72%	533,590 $30.5 Million
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $27.8 Million - $31 Million	578,253	578,253 $30.9 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deprince Race & Zollo Inc with notifications on news.

Account